BNP Paribas Asset Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-284,891
| Closed | -$19.4M | – | 936 |
|
|
2022
Q3 | $19.4M | Sell |
284,891
-666,220
| -70% | -$45.4M | 0.08% | 285 |
|
|
2022
Q2 | $30.4M | Buy |
951,111
+308,207
| +48% | +$9.85M | 0.12% | 205 |
|
|
2022
Q1 | $22.3M | Buy |
642,904
+242,117
| +60% | +$8.39M | 0.08% | 285 |
|
|
2021
Q4 | $11.7M | Buy |
400,787
+86,714
| +28% | +$2.54M | 0.04% | 419 |
|
|
2021
Q3 | $8M | Sell |
314,073
-274,848
| -47% | -$7M | 0.03% | 452 |
|
|
2021
Q2 | $20.6M | Buy |
588,921
+52,099
| +10% | +$1.82M | 0.07% | 307 |
|
|
2021
Q1 | $21.9M | Buy |
536,822
+278,667
| +108% | +$11.4M | 0.09% | 263 |
|
|
2020
Q4 | $11.2M | Sell |
258,155
-42,558
| -14% | -$1.84M | 0.05% | 363 |
|
|
2020
Q3 | $16.6M | Buy |
300,713
+66,695
| +28% | +$3.68M | 0.09% | 245 |
|
|
2020
Q2 | $14.8M | Buy |
+234,018
| New | +$14.8M | 0.1% | 236 |
|